Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Voyager Therapeutics (VYGR) Return on Assets (2016 - 2025)

Historic Return on Assets for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to 0.42%.

  • Voyager Therapeutics' Return on Assets fell 4800.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year decrease of 4800.0%. This contributed to the annual value of 0.17% for FY2024, which is 6900.0% down from last year.
  • According to the latest figures from Q3 2025, Voyager Therapeutics' Return on Assets is 0.42%, which was down 4800.0% from 0.32% recorded in Q2 2025.
  • In the past 5 years, Voyager Therapeutics' Return on Assets ranged from a high of 0.41% in Q4 2023 and a low of 0.52% during Q3 2021
  • For the 5-year period, Voyager Therapeutics' Return on Assets averaged around 0.08%, with its median value being 0.1% (2022).
  • As far as peak fluctuations go, Voyager Therapeutics' Return on Assets tumbled by -6600bps in 2021, and later soared by 7300bps in 2023.
  • Over the past 5 years, Voyager Therapeutics' Return on Assets (Quarter) stood at 0.39% in 2021, then soared by 31bps to 0.27% in 2022, then skyrocketed by 251bps to 0.41% in 2023, then tumbled by -139bps to 0.16% in 2024, then plummeted by -162bps to 0.42% in 2025.
  • Its Return on Assets stands at 0.42% for Q3 2025, versus 0.32% for Q2 2025 and 0.23% for Q1 2025.